Eigen Therapeutics is a biotechnology company on a mission to make therapies that make cancer easier to find and eliminate. Eigen is focused on the development of “priming” therapies, therapies that help targeted therapies reach their full potential by addressing cancer heterogeneity, making cancer cells more vulnerable and/or making healthy cells more resilient to treatment.
Eigen is building a high-throughput discovery platform to explore the space of priming therapies, leveraging proprietary machine learning algorithms to discover novel associations, new classes of drugs, and new potential therapies that change a cell's state to make it more vulnerable to a targeted therapy. The Eigen platform represents the intersection of biology and engineering, and includes robotic systems, laboratory operations software, and machine learning analysis pipelines—all developed in-house—with the ultimate goal of saving more lives.
Company Details
- Employees
- 9
- Founded
- -
- Address
- Redwood City, Ca 94063, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.eigentx.com
- HQ
- Redwood City, CA
Eigen Therapeutics Questions
Eigen Therapeutics's website is https://www.eigentx.com
Eigen Therapeutics's LinkedIn profile is https://www.linkedin.com/company/eigentherapeutics
Eigen Therapeutics has
9 employees.
View email and phone details for 9
employees at Eigen Therapeutics.
Eigen Therapeutics's industry is
Biotechnology Research
Eigen Therapeutics's top competitors are
Notable,
Dren Bio, Inc.,
Immune-Onc Therapeutics,
Hepta Bio,
Vibe Bio,
Zaka Vc,
Genesis Therapeutics,
Biotechtv,
Senti Biosciences,
Asher Biotherapeutics.
Eigen Therapeutics's categories are Biotechnology Research
Eigen Therapeutics's founding year is 2021
